Illumina, Inc. (ILMN) Stake Raised by State of Tennessee Treasury Department

State of Tennessee Treasury Department raised its stake in shares of Illumina, Inc. (NASDAQ:ILMN) by 7.8% during the first quarter, according to its most recent filing with the SEC. The fund owned 97,850 shares of the life sciences company’s stock after buying an additional 7,040 shares during the period. State of Tennessee Treasury Department’s holdings in Illumina were worth $16,697,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in the stock. Forte Capital LLC ADV boosted its position in Illumina by 1.6% in the first quarter. Forte Capital LLC ADV now owns 2,185 shares of the life sciences company’s stock valued at $373,000 after buying an additional 35 shares during the last quarter. Gemmer Asset Management LLC boosted its position in Illumina by 5.7% in the first quarter. Gemmer Asset Management LLC now owns 686 shares of the life sciences company’s stock valued at $117,000 after buying an additional 37 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in Illumina by 0.6% in the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 8,421 shares of the life sciences company’s stock valued at $1,078,000 after buying an additional 48 shares during the last quarter. Stanford Investment Group Inc. boosted its position in Illumina by 5.7% in the fourth quarter. Stanford Investment Group Inc. now owns 1,400 shares of the life sciences company’s stock valued at $179,000 after buying an additional 75 shares during the last quarter. Finally, Girard Securities Inc. boosted its position in Illumina by 5.1% in the fourth quarter. Girard Securities Inc. now owns 2,065 shares of the life sciences company’s stock valued at $264,000 after buying an additional 100 shares during the last quarter. 92.79% of the stock is currently owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)

Shares of Illumina, Inc. (NASDAQ:ILMN) traded up 0.64% on Friday, hitting $177.01. 1,061,794 shares of the company were exchanged. Illumina, Inc. has a 52-week low of $119.37 and a 52-week high of $189.48. The stock has a market capitalization of $25.84 billion, a PE ratio of 35.82 and a beta of 0.79. The firm’s 50-day moving average is $178.41 and its 200-day moving average is $156.53.

Illumina (NASDAQ:ILMN) last announced its quarterly earnings data on Tuesday, April 25th. The life sciences company reported $0.64 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.64. Illumina had a net margin of 19.31% and a return on equity of 22.89%. The company had revenue of $598 million during the quarter, compared to analysts’ expectations of $590.51 million. During the same quarter in the prior year, the company earned $0.71 EPS. Illumina’s revenue was up 4.5% compared to the same quarter last year. Equities research analysts predict that Illumina, Inc. will post $3.63 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “Illumina, Inc. (ILMN) Stake Raised by State of Tennessee Treasury Department” was originally posted by Mideast Time and is owned by of Mideast Time. If you are viewing this article on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark legislation. The correct version of this article can be read at https://www.mideasttime.com/illumina-inc-ilmn-stake-raised-by-state-of-tennessee-treasury-department/1708071.html.

ILMN has been the topic of a number of recent research reports. Vetr raised Illumina from a “sell” rating to a “buy” rating and set a $175.76 target price on the stock in a report on Tuesday, January 24th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $155.00 target price on shares of Illumina in a report on Wednesday, February 1st. Leerink Swann raised their target price on Illumina from $134.00 to $138.00 and gave the stock a “market perform” rating in a report on Thursday, February 9th. Canaccord Genuity reaffirmed a “hold” rating and issued a $150.00 target price on shares of Illumina in a report on Tuesday, February 21st. Finally, Evercore ISI raised Illumina from a “hold” rating to a “buy” rating and set a $190.00 target price on the stock in a report on Monday, February 27th. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $164.97.

In related news, EVP Omead Ostadan sold 1,672 shares of the company’s stock in a transaction dated Friday, March 24th. The shares were sold at an average price of $170.00, for a total transaction of $284,240.00. Following the completion of the sale, the executive vice president now owns 29,586 shares of the company’s stock, valued at approximately $5,029,620. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Daniel Bradbury sold 600 shares of the company’s stock in a transaction dated Tuesday, March 21st. The shares were sold at an average price of $163.56, for a total transaction of $98,136.00. Following the sale, the director now directly owns 17,065 shares of the company’s stock, valued at approximately $2,791,151.40. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 35,521 shares of company stock valued at $6,465,772. 1.60% of the stock is owned by corporate insiders.

Illumina Company Profile

Illumina, Inc (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations.

5 Day Chart for NASDAQ:ILMN

Want to see what other hedge funds are holding ILMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Illumina, Inc. (NASDAQ:ILMN).

Receive News & Ratings for Illumina Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina Inc. and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.